Vertex Pharmaceuticals
VRTX
#179
Rank
A$170.87 B
Marketcap
A$666.47
Share price
-0.16%
Change (1 day)
-9.44%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): A$6.93 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are A$11.72 Billion. In 2024 the company made an earning of A$0.41 Billion a decrease over its 2023 earnings that were of A$6.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$6.93 B1554.45%
2024 A$0.41 B-93.69%
2023 A$6.64 B3.19%
2022 A$6.43 B53.56%
2021 A$4.19 B-12.06%
2020 A$4.76 B118.45%
2019 A$2.18 B120.64%
2018 A$0.98 B1473.64%
2017 A$62.84 M197.6%
2016 A$21.11 M-102.97%
2015 -A$0.72 Billion-28.46%
2014 -A$1 Billion-51.5%
2013 -A$2.05 Billion-30584.68%
2012 A$6.72 M-95.47%
2011 A$0.14 B
2009 -A$0.89 Billion
2007 -A$0.62 Billion83.1%
2006 -A$0.34 Billion59.02%
2005 -A$0.22 Billion3.28%
2004 -A$0.21 Billion-38.16%
2003 -A$0.34 Billion
2000 -A$57.12 Million-20.38%
1999 -A$71.73 Million31.62%
1998 -A$54.5 Million91.05%
1997 -A$28.53 Million-36.24%
1996 -A$44.74 Million12.45%
1995 -A$39.79 Million27.4%
1994 -A$31.23 Million-1833.33%
1993 A$1.8 M-112.12%
1992 -A$14.87 Million175%
1991 -A$5.41 Million-12.2%
1990 -A$6.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$14.84 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.49 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.66 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.05 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.63 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-A$0.13 Billion-101.93%๐Ÿ‡บ๐Ÿ‡ธ USA